Pharmacies must stop compounding semaglutide by May 22, 2025, though existing stocks may still be dispensed until expiration
The retatrutide Phase 2 obesity trial , published in the New England Journal of Medicine, demonstrated weight loss of up to 24.2% at the 12mg dose after just 48 weeks
This could be because people who have learned to eat more healthily and exercise more often continue to do so even as they regain weight
Galliprant (grapiprant tablets) Indications: Galliprant controls pain and inflammation associated with osteoarthritis in dogs
If you experience any side effects or notice signs of dehydration, such as feeling very thirsty, having dark yellow urine, or feeling lightheaded, contact your healthcare provider
Nasal delivery is an emerging option with biological rationale but limited human evidence